
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
Upturn AI SWOT
- About
Moolec Science SA Warrant (MLECW)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
03/13/2025: MLECW (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type Stock | Historic Profit -73.81% | Avg. Invested days 28 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) 8192 | Beta -0.48 | 52 Weeks Range 0.01 - 0.17 | Updated Date 02/26/2025 |
52 Weeks Range 0.01 - 0.17 | Updated Date 02/26/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) - |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -140.33% | Operating Margin (TTM) -134.97% |
Management Effectiveness
Return on Assets (TTM) -20.16% | Return on Equity (TTM) -104.72% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value - | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating 7319859 |
Shares Outstanding - | Shares Floating 7319859 | ||
Percent Insiders - | Percent Institutions - |
Analyst Ratings
Rating - | Target Price - | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Moolec Science SA Warrant
Company Overview
History and Background
Moolec Science SA is a food technology company focusing on molecular farming. The warrant is related to their public listing and future stock purchasing rights.
Core Business Areas
- Molecular Farming: Develops real animal proteins in plants, enhancing nutritional value and sustainability.
- Ingredient Development: Creating innovative food ingredients using plant-based platforms.
Leadership and Structure
Information on the leadership team and organizational structure is available in their public filings and on their website. Generally structured around scientific, operational and financial expertise.
Top Products and Market Share
Key Offerings
- Soybean Seed Oil Rich in Bovine Protein: Developing a soybean variety enriched with bovine protein. Market share data is emerging as the product is still under development. Competitors are traditional animal protein producers and other plant-based protein companies like Beyond Meat (BYND) and Impossible Foods.
- Pig Procollagen in Soybean: Using soybeans to produce pig procollagen. Competitors are companies that produce procollagen via conventional methods, and companies in the alternative protein space such as Ginkgo Bioworks (DNA).
Market Dynamics
Industry Overview
The food technology industry is rapidly growing, driven by increasing demand for sustainable and ethical food sources. Molecular farming is a novel approach within this landscape.
Positioning
Moolec Science is positioned as a pioneer in molecular farming, aiming to disrupt the traditional animal protein market with plant-based alternatives. Their competitive advantage lies in their patented technology and unique product offerings.
Total Addressable Market (TAM)
The TAM for alternative protein is projected to reach hundreds of billions of dollars in the coming years. Moolec aims to capture a significant share of this market by offering sustainable and cost-effective protein sources.
Upturn SWOT Analysis
Strengths
- Innovative technology
- Strong intellectual property
- First-mover advantage in molecular farming
- Potential for cost-effective protein production
Weaknesses
- Technology is still under development
- Limited commercialization experience
- Regulatory hurdles
- Market acceptance risk
Opportunities
- Growing demand for sustainable protein
- Partnerships with food companies
- Expansion into new markets
- Increasing investment in food technology
Threats
- Competition from established protein producers
- Regulatory changes
- Technological disruptions
- Consumer skepticism
Competitors and Market Share
Key Competitors
- BYND
- IMMP
- DNA
- INGR
Competitive Landscape
Moolec's competitive advantage lies in its novel molecular farming approach, but it faces challenges from established protein producers and other alternative protein companies. The market share of MLECW is relatively small compared to BYND and INGR.
Major Acquisitions
Growth Trajectory and Initiatives
Historical Growth: Historical growth is limited due to the company's early stage. Future growth depends on successful product development, regulatory approvals, and market acceptance.
Future Projections: Future projections vary depending on analyst estimates, but are largely positive given the growing demand for sustainable protein.
Recent Initiatives: Recent initiatives include ongoing research and development efforts, partnerships with industry stakeholders, and preparations for commercial product launches.
Summary
Moolec Science SA is a high-risk, high-reward food technology company pioneering molecular farming. Its strength is in its innovative approach, but it faces challenges in technology development, regulation, and market acceptance. Successful commercialization could result in significant growth, but failures could lead to substantial losses. Investment should be carefully considered given the uncertain outcomes. Focus is needed on R&D and on regulatory hurdles.
Similar Companies

BYND

Beyond Meat Inc



BYND

Beyond Meat Inc
DNA

Ginkgo Bioworks Holdings


DNA

Ginkgo Bioworks Holdings

IMMP

Immutep Ltd ADR



IMMP

Immutep Ltd ADR

INGR

Ingredion Incorporated



INGR

Ingredion Incorporated
Sources and Disclaimers
Data Sources:
- Company SEC filings
- Industry reports
- Analyst estimates
- Company Press Releases
Disclaimers:
This analysis is for informational purposes only and does not constitute financial advice. Investment decisions should be based on individual research and consultation with a qualified financial advisor. Market share estimates are approximate and subject to change.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Moolec Science SA Warrant
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2023-01-03 | Co-Founder, CEO & Director Mr. Gaston Paladini M.B.A. | ||
Sector Healthcare | Industry Biotechnology | Full time employees 52 | Website https://moolecscience.com |
Full time employees 52 | Website https://moolecscience.com |
Moolec Science SA, a science-based food ingredient company, focuses on developing ingredients for food, pet food, animal feed, and dietary supplements using molecular farming technology. It develops textured soy proteins, safflower oil, meat replacement products, food ingredients, and nutritional supplements. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg, Luxembourg.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.